Artelo Biosciences (ARTL) Cash & Current Investments (2014 - 2025)
Artelo Biosciences (ARTL) posted quarterly Cash & Current Investments of $600000.0 for Q4 2025, down 74.34% year-over-year from $2.3 million in Q4 2024, and down 65.12% quarter-over-quarter from $1.7 million in Q3 2025.
Artelo Biosciences (ARTL) Cash & Current Investments (2014 - 2025) Analysis & Trends
Artelo Biosciences (ARTL) has reported Cash & Current Investments for 12 consecutive years, with $600000.0 the latest figure, recorded in Q4 2025.
- In Q4 2025, Cash & Current Investments fell 74.34% year-over-year to $600000.0; the TTM figure through Dec 2025 stood at $600000.0 (down 74.34% YoY), while the FY2025 annual figure was $600000.0, down 74.34% from the prior year.
- Cash & Current Investments declined to $600000.0 in Q4 2025 per ARTL's latest filing, from $1.7 million in the prior quarter.
- Across five years, Cash & Current Investments topped out at $26.4 million in Q4 2021 and bottomed at $600000.0 in Q4 2025.
- Historically, Cash & Current Investments has averaged $7.3 million across 5 years, with a median of $6.8 million in 2021.
- Annual changes were most pronounced in 2021 — Cash & Current Investments soared 685.79% — and 2025, when it slumped 90.2%.
- Artelo Biosciences' Cash & Current Investments stood at $26.4 million in 2021, then slumped by 68.2% to $8.4 million in 2022, then grew by 24.37% to $10.4 million in 2023, then slumped by 77.58% to $2.3 million in 2024, then tumbled by 74.34% to $600000.0 in 2025.
- Business Quant data shows ARTL's Cash & Current Investments at $600000.0 in Q4 2025, $1.7 million in Q3 2025, and $2.1 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 7.85 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 7.99 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 5.18 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 5.14 Bn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 5.10 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 3.31 Bn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 18.39 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 1.16 Bn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 836.99 Mn |
| 10 | Artelo Biosciences | 107,735.40 | -492,264.60 | - | 600,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 600,000.00 |
| Sep 30, 2025 | 1.72 Mn |
| Jun 30, 2025 | 2.07 Mn |
| Mar 31, 2025 | 746,000.00 |
| Dec 31, 2024 | 2.34 Mn |
| Sep 30, 2024 | 4.86 Mn |
| Jun 30, 2024 | 5.60 Mn |
| Mar 31, 2024 | 7.61 Mn |
| Dec 31, 2023 | 10.43 Mn |
| Sep 30, 2023 | 2.64 Mn |
| Jun 30, 2023 | 5.72 Mn |
| Mar 31, 2023 | 6.92 Mn |
| Dec 31, 2022 | 8.38 Mn |
| Sep 30, 2022 | 8.62 Mn |
| Jun 30, 2022 | 12.12 Mn |
| Mar 31, 2022 | 12.35 Mn |
| Nov 30, 2021 | 26.37 Mn |
| Aug 31, 2021 | 6.63 Mn |
| May 31, 2021 | 10.05 Mn |
| Feb 28, 2021 | 11.22 Mn |